Cargando…
The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?
SIMPLE SUMMARY: This review aims to provide an outline of the potential use of plant-based foods, nutraceuticals, and derived micronutrients—particularly those typically found in the Mediterranean diet—as anticancer agents, with a focus on their mechanism of action as cyclin-dependent kinase inhibit...
Autores principales: | Benot-Dominguez, Reyes, Cimini, Annamaria, Barone, Daniela, Giordano, Antonio, Pentimalli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179653/ https://www.ncbi.nlm.nih.gov/pubmed/35681689 http://dx.doi.org/10.3390/cancers14112709 |
Ejemplares similares
-
Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity
por: Iqbal, Niloy Jafar, et al.
Publicado: (2018) -
PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019) -
The cyclin dependent kinase inhibitor Roscovitine prevents diet-induced metabolic disruption in obese mice
por: Rabhi, Nabil, et al.
Publicado: (2021) -
Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade
por: Indovina, Paola, et al.
Publicado: (2020) -
Corrigendum: Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2020)